Cite
Annala M, Taavitsainen S, Khalaf DJ, et al. Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition. Clin Cancer Res. 2021;27(16):4610-4623doi: 10.1158/1078-0432.CCR-21-1625.
Annala, M., Taavitsainen, S., Khalaf, D. J., Vandekerkhove, G., Beja, K., Sipola, J., Warner, E. W., Herberts, C., Wong, A., Fu, S., Finch, D. L., Oja, C. D., Vergidis, J., Zulfiqar, M., Eigl, B. J., Kollmansberger, C. K., Nykter, M., Gleave, M. E., Chi, K. N., & Wyatt, A. W. (2021). Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(16), 4610-4623. https://doi.org/10.1158/1078-0432.CCR-21-1625
Annala, Matti, et al. "Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,16 (2021): 4610-4623. doi: https://doi.org/10.1158/1078-0432.CCR-21-1625
Annala M, Taavitsainen S, Khalaf DJ, Vandekerkhove G, Beja K, Sipola J, Warner EW, Herberts C, Wong A, Fu S, Finch DL, Oja CD, Vergidis J, Zulfiqar M, Eigl BJ, Kollmansberger CK, Nykter M, Gleave ME, Chi KN, Wyatt AW. Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition. Clin Cancer Res. 2021 Aug 15;27(16):4610-4623. doi: 10.1158/1078-0432.CCR-21-1625. Epub 2021 Jun 03. PMID: 34083234.
Copy
Download .nbib